|
Antifungal agents. Part II. The azoles
|
Before 1978, amphotericin B and flucytosine were the only drugs available for the treatment of systemic fungal infections. The imidazoles, miconazole and ketoconazole, were introduced during the next 3 years. Intravenously administered miconazole served a limited therapeutic role and is no longer
available. Orally administered ketoconazole, an inexpensive, effective, and convenient option for treating mucosal candidiasis, was widely used for a decade because it was the only available oral therapy for systemic fungal infections. During the 1990s, use of ketoconazole diminished because of the
...
Related newspaper, magazine, and trade journal articles from HighBeam Research
(Including press releases, facts, information, and biographies)
|
Systemic fungal infections in neonates
; ...mortality in these babies. Systemic fungal infections, previously considered...common and severe in systemic fungal infections and can involve the kidneys...mainstay of therapy for systemic fungal infections. The optimal daily dosage...
|
|
Twenty years later, fungal infections, emergence of resistance still on rise
; ...Cutaneous and systemic fungal infections have increased...superficial and deep fungal infections. Trends in the...of nosocomial fungal infections reveal the frequency...opportunistic fungal infections cannot be diagnosed...
|
|
|
Microbiology of systemic fungal infections
; ...The data on burden of systemic fungal infections in India are not clear...substantial increase in systemic fungal infections, including better management...antibiotics. The etiology of systemic fungal infections can be broadly classified...
|
|
SEQUUS Pharmaceuticals receives approval to market AMPHOCIL in Holland
; ...AMPHOCIL has been approved for the treatment of systemic fungal infections in patients for whom conventional therapy...addition to its use as a second-line therapy for systemic fungal infections, SEQUUS says it is developing AMPHOCIL for...
|
|
Recognizing skin lesions of systemic fungal infections in patients with AIDS.
; ...mucocutaneous lesions of systemic fungal infections in HIV-positive patients...cutaneous lesions of systemic fungal infections in HIV-positive patients...disseminating fungal organisms. Systemic Fungal Infections Mucocutaneous lesions...
|
|
|
Endocrine and Metabolic Manifestations of Invasive Fungal Infections and Systemic Antifungal Treatment
; ...metabolic complications of fungal infections and antifungal therapy...production The incidence of systemic fungal infections is increasing in immunocompromised...with central nervous system fungal infections. Of 40 patients with intracranial...
|
|
|
Editorial Note
; ...life-threatening systemic fungal infection but also...microbiology of fungal infections by Dr Arunaloke...leishmaniasis and systemic fungal infections in various types...with patients with systemic fungal infections and leishmaniasis...AA. Disseminated ...
|
|
Nyotran pact.
; ...international rights to Nyotran, Aronex' proprietary injectable formulation of nystatin for the treatment of systemic fungal infections. The anti-infective is currently involved in Phase III trials.
|
|
|
FDA ok's Liposome's amphotericin B lipid complex to treat aspergillosis in immune compromised patients
; ...has been marketed for many years for the treatment of systemic fungal infections. It has been generally considered the treatment of choice...potential to cause damage to the kidneys. Aspergillosis is a systemic fungal infection that commonly affects patients whose immune...
|
|
Changing populations driving fungal infections
; Fungal infections are on the increase, but not for...patients are sicker. Higher rates of fungal infections are related to higher success...University Hospital in Camden, N.J. "Fungal infections are largely diseases of medical...
|
For more facts and information,
see all results
Find more facts and
information related to the
article "Antifungal agents. Part II. The azoles".
